Drugs News and Research

RSS

ACC/AHA release consensus document to help clinicians reduce risk of hypertension in older adults

Hypertension is very common among older adults. 64 percent of older men and 78 percent of older women have high blood pressure, placing them at heightened risk for heart disease including heart failure, stroke, coronary artery disease and atrial fibrillation, as well as chronic kidney disease and diabetes mellitus.

26 Apr 2011

Scientists identify key enzyme that destroys lung tissue in TB

Scientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis, they report today in the Journal of Clinical Investigation. Drugs that inhibit this enzyme are already available, meaning that the finding could lead quickly to new treatments.

26 Apr 2011

Study: HIV infection linked to increased risk of heart failure

Patients with HIV infection without a prior history of coronary heart disease may be at a higher risk of developing heart failure, according to a report in the April 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

26 Apr 2011

Aetna achieves full pharmacy benefit management accreditation from URAC

Aetna Pharmacy Management today announced that it has been awarded full pharmacy benefit management accreditation from URAC, an independent health care accrediting organization that evaluates and monitors PBM's for quality, safety and effectiveness.

26 Apr 2011

Signaling pathway reveals mechanism for B cell differentiation in immune response

An article in Science Signaling by researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) has clarified for the first time the mechanism governing differentiation of B cells into antibody-producing plasma cells. The finding establishes a role for the extracellular signal-regulated kinase (ERK) signaling pathway in B cell differentiation, a key step toward the development of B cell-targeted drugs for treatment of autoimmune diseases and allergies.

25 Apr 2011

Kadmon Pharmaceuticals and Nano Terra announce worldwide licensing agreement

Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra’s drug discovery platform, Pharmacomer™ Technology. The product candidates and technology platform will be transferred to a newly formed joint venture, NT Life Sciences (“NT Life”), co-owned by Kadmon and Nano Terra, which will act as the licensor and recipient of any licensing or royalty fees subject to the agreement. Terms of the agreement were not disclosed.

25 Apr 2011

Study questions suitability of anti-retroviral drugs for the young

According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.

25 Apr 2011

MonoSol Rx, KemPharm enter development and commercialization partnership for ADHD prodrug

MonoSol Rx, LLC, the developer of PharmFilm® drug delivery technology, today announced that the Company has entered into a development and commercialization partnership with KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease.

25 Apr 2011

Supreme Court to weigh drug confidentiality laws

Marketing to doctors using prescription records bearing their names is an increasingly contentious practice, with three states, Maine, New Hampshire and Vermont, in the vanguard of enacting laws to limit the uses of a doctor's prescription records for marketing.

25 Apr 2011

Pharmasset reports net loss of $19.9 million for quarter ended March 31, 2011

Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2011.

25 Apr 2011

New book on aging

Aging is a natural part of life. From the minute we are born we are heading in one certain direction: towards death. That said, it is possible to arrive at that ultimate destination graceful and vital to our last days rather than chronically ill suffering from one or many debilitating illnesses.

25 Apr 2011

U.N. Secretary-General calls for scale up of global malaria efforts ahead of World Malaria Day

Global malaria control efforts must be significantly scaled up if the world is to reach the goal of reducing malaria deaths to almost zero by 2015, U.N. Secretary-General Ban Ki-moon said in a message on Thursday ahead of World Malaria Day, which is officially observed on Monday, the U.N. News Centre writes.

25 Apr 2011

Research sheds light on molecular movements of neural transporters

A team of scientists from Columbia University College of Physicians and Surgeons and Weill Cornell Medical College has shed light on the molecular workings of transporter proteins, molecular machines embedded in the cell membranes of neurons that modulate the transfer of signals between cells and recycle neurotransmitters.

25 Apr 2011

AHF opposes Florida officials' AIDS budget proposal at 'Rule 64D' hearings

Beginning Monday April 25th the Florida Department of Health is conducting four public hearings on proposed reductions to the eligibility threshold to Florida's AIDS Drug Assistance Program, AIDS Insurance Continuation Program, Housing Opportunities for Persons with AIDS, and possibly other Ryan White funded programs and services.

25 Apr 2011

AP reports on Global Fund malaria drug thefts, issues correction

The Associated Press on Wednesday published an article reporting that hundreds of millions of dollars of malaria medication had been stolen from the Global Fund to Fight AIDS, Tuberculosis and Malaria, but later issued a correction.

25 Apr 2011

Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment

Sequella, a clinical-stage pharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, and Maxwell Biotech Venture Fund announced their agreement to complete the clinical development and commercialize SQ109 for treatment of tuberculosis in the Russian Federation and neighboring Commonwealth of Independent States countries, including Armenia, Azerbaijan, Belorussia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, and Ukraine.

25 Apr 2011

Nano Terra, Kadmon sign deal to license novel product candidates

25 Apr 2011

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

More than 1,800 Chinese oncology professionals attended the NCCN 4th Annual Asia Scientific Congress in Shanghai, China, on April 9, 2011, which featured expert faculty from NCCN Member Institutions and thought leaders in cancer care from major Chinese cancer centers.

25 Apr 2011

Creative approach can tackle bacterial infections in patients with cystic fibrosis

An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.

25 Apr 2011

Viewpoints: Gov. Walker on 'obsolete' Medicaid; Are patients consumers?; The Onion pokes fun at Romney

What does Medicaid have in common with "I Dream of Jeannie," "Lost in Space" and "Get Smart"? They all made their debut in 1965. ... the television networks have updated their programming.

22 Apr 2011

Drugs News and Research

ACC/AHA release consensus document to help clinicians reduce risk of hypertension in older adults

Scientists identify key enzyme that destroys lung tissue in TB

Study: HIV infection linked to increased risk of heart failure

Aetna achieves full pharmacy benefit management accreditation from URAC

Signaling pathway reveals mechanism for B cell differentiation in immune response

Kadmon Pharmaceuticals and Nano Terra announce worldwide licensing agreement

Study questions suitability of anti-retroviral drugs for the young

MonoSol Rx, KemPharm enter development and commercialization partnership for ADHD prodrug

Supreme Court to weigh drug confidentiality laws

Pharmasset reports net loss of $19.9 million for quarter ended March 31, 2011

New book on aging

U.N. Secretary-General calls for scale up of global malaria efforts ahead of World Malaria Day

Research sheds light on molecular movements of neural transporters

AHF opposes Florida officials' AIDS budget proposal at 'Rule 64D' hearings

AP reports on Global Fund malaria drug thefts, issues correction

Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment

Nano Terra, Kadmon sign deal to license novel product candidates

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

Creative approach can tackle bacterial infections in patients with cystic fibrosis

Viewpoints: Gov. Walker on 'obsolete' Medicaid; Are patients consumers?; The Onion pokes fun at Romney

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News